Alaunos Therapeutics Inc’s recent filing unveils that its Director Vieser Jaime unloaded Company’s shares for reported $6022.0 on Dec 31 ’24. In the deal valued at $2.01 per share,3,000 shares were sold. As a result of this transaction, Vieser Jaime now holds 25,894 shares worth roughly $55931.04.
Then, Vieser Jaime bought 3,000 shares, generating $6,510 in total proceeds.
Price Performance Review of TCRT
On Tuesday, Alaunos Therapeutics Inc [NASDAQ:TCRT] saw its stock jump 46.94% to $2.16. Over the last five days, the stock has gained 34.10%. Alaunos Therapeutics Inc shares have risen nearly 13.39% since the year began. Nevertheless, the stocks have fallen -88.07% over the past one year. While a 52-week high of $18.90 was reached on 04/01/25, a 52-week low of $1.31 was recorded on 03/31/25. SMA at 50 days reached $1.6000, while 200 days put it at $2.7800.
Levels Of Support And Resistance For TCRT Stock
The 24-hour chart illustrates a support level at 1.4200, which if violated will result in even more drops to 0.6700. On the upside, there is a resistance level at 2.8300. A further resistance level may holdings at 3.4900. The Relative Strength Index (RSI) on the 14-day chart is 74.26, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1600, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.08%. Stochastics %K at 44.17% indicates the stock is a holding.
How much short interest is there in Alaunos Therapeutics Inc?
A steep rise in short interest was recorded in Alaunos Therapeutics Inc stocks on 2025-03-14, dropping by 2570.0 shares to a total of 51732.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 54302.0 shares. There was a decline of -4.97%, which implies that there is a negative sentiment for the stock.
